Peptides Lack Reliable Safety Information, Watchdog Warns of the Federal Food, Drug, and Cosmetic Act (FDCA).* The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 Banned: Key Facts on the Latest FDA Decision